1. Market Research
  2. > Pathology
33 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025

  • $ 22000
  • April 2018
  • 229 pages

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025 TABLE OF CONTENTS Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVERVIEW AND TRENDS ## METHODOLOGY

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034

  • $ 22000
  • April 2018
  • 196 pages

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034 TABLE OF CONTENTS & nbsp; (Forecast, Treatment and Epidemiology Datapacks included) & nbsp; ## FORECAST: MANTLE CELL LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034

  • $ 22000
  • April 2018
  • 162 pages

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034 TABLE OF CONTENTS & nbsp; (Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: DIFFUSE LARGE B-CELL LYMPHOMA (Published on ## August 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVE

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

NHL: Diffuse large Bcell lymphoma

  • $ 5000
  • May 2016
  • 219 pages

Immunophenotyping also needs to be robust enough to distinguish the disease from other lymphomas which resemble DLBCL in morphology, such as mantle cell lymphoma and Burkitt' s lymphoma.

  • Cancer
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • United States

NHL: Follicular lymphoma

  • $ 5000
  • April 2016
  • 252 pages

NHL: Follicular lymphoma Disease Coverage | Treatment: Follicular Lymphoma practices.

  • Cancer
  • Healthcare
  • Lymphoma
  • Monoclonal Antibody
  • Therapy

NHL: Mantle cell lymphoma

  • $ 5000
  • April 2016
  • 214 pages

Lymphoma Association (2016) Mantle cell lymphoma.

  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy

Market Spotlight: Tumor Lysis Syndrome (TLS)

  • $ 16500
  • March 2018
  • 33 pages

& nbsp; Key Takeaways& nbsp; Datamonitor Healthcare estimates that in 2016, there were approximately ##, ## incident cases of tumor lysis syndrome (TLS) worldwide among individuals with high-risk malignancies (acute myeloid leukemia, acute lymphocytic leukemia, and Burkitt’s lymphoma)

  • Cancer
  • Leukemia
  • Lymphoma
  • United States
  • World

Market Spotlight: Peripheral T-Cell Lymphoma (PTCL)

  • $ 16500
  • March 2018
  • 35 pages

This Market Spotlight report covers the Peripheral T-Cell Lymphoma market, comprising key marketed and pipeline drugs, clinical trials, upcoming events, patent information, a 10-year disease incidence ...

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Forecast

Drug Overview: Celgene

  • $ 3000
  • March 2018
  • 49 pages

Model updates adjusted Revlimid forecast: removed chronic lymphocytic leukemia indication expansion; removed newly diagnosed follicular lymphoma indication expansion early generic entry for Abraxane in Q## 2022 CC-##’s launch delayed to Q## 2019 ozanimod’s launch in relapsing multiple sclero

  • Lymphoma
  • Prescription Drug
  • Demand

Acute lymphoblastic leukemia

  • $ 5000
  • April 2016
  • 193 pages

Leukemia & Lymphoma, ##(##), ##-## < DOI> ##. ##/ ##. 2011. ##< / DOI>.

  • Immunotherapy
  • Leukemia
  • Lymphoma
  • Monoclonal Antibody
  • Therapy

Chronic myeloid leukemia

  • $ 5000
  • May 2016
  • 219 pages

Leukemia & Lymphoma, ##(##), ##-##.

  • Healthcare
  • Leukemia
  • Lymphoma
  • Therapy
  • ARIAD Pharmaceuticals, Inc.

Gastric cancer

  • $ 5000
  • July 2016
  • 249 pages

The remaining ##-##% of gastric cancers arise from lymphomas, gastrointestinal stromal tumors, and carcinoid tumors (American Cancer Society, 2015) JAPAN HAS THE HIGHEST INCIDENCE RATE OF GASTRIC CANCER OUT OF THE SEVEN MARKETS SURVEYED Japan has the highest gastric cancer incidence rate of

  • Chemotherapy
  • Gastric Cancer
  • Lymphoma
  • Monoclonal Antibody
  • Therapy

Atopic dermatitis

  • $ 5000
  • January 2016
  • 184 pages

Dupilumab is expected to be the first biologic approved for atopic dermatitis, offering a novel treatment option for the most severe patients and driving a strong CAGR of 15.6% during the 2015–24 forecast ...

  • Dermatological Condition
  • Healthcare
  • Lymphoma
  • Pathology
  • Therapy

Pharma's Patient Centricity

  • $ 5000
  • February 2016
  • 45 pages

Trends Hot Topic Ref Code: Downloaded on: Author: DMKC## Melanie Senior Outcomes-focused payers, new technologies, and empowered consumers are pushing pharma towards patient-centric drug development and commercialization.

  • Lymphoma
  • Pharmaceutical
  • World
  • AstraZeneca PLC

Breast cancer: triple - negative

  • $ 5000
  • May 2016
  • 290 pages

lymphomas (cancer of the lymph tissue) develop in the breasts.

  • Breast Cancer
  • Cancer
  • Lymphoma
  • Targeted Therapy
  • Therapy

Drug analysis: Keytruda

  • $ 10000
  • December 2017
  • 120 pages

lymphoma (DLBCL) Keytruda : Gastric cancer Keytruda : Breast cancer: triple-negative Keytruda : Melanoma Keytruda : Multiple myeloma LIST OF FIGURES Figure ##: Keytruda for colorectal cancer – SWOT analysis Figure ##: Datamonitor Healthcare’s drug assessment summary for Keytruda in colorecta

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • Japan

HIV

  • $ 5000
  • January 2016
  • 455 pages

Despite the anticipated launch of generics of blockbuster brands, an increase in HIV prevalence and continued uptake of premium single-tablet regimens (STRs) will drive continued market growth during ...

  • Antiviral
  • HIV AIDS
  • Lymphoma
  • Therapy
  • United States

Market Spotlight: Cutaneous T-Cell Lymphoma (CTCL)

  • $ 16500
  • March 2018
  • 40 pages

This Market Spotlight report covers the Cutaneous T-Cell Lymphoma (CTCL) market, comprising key pipeline and marketed drugs, clinical trials, upcoming events, patent information, a 10-year disease incidence ...

  • Lymphoma
  • United States
  • World
  • M&A

Breast cancer: HR+/HER2-

  • $ 5000
  • April 2016
  • 273 pages

lymphomas (cancer of the lymph tissue) develop in the breasts.

  • Breast Cancer
  • Cancer
  • Lymphoma
  • Monoclonal Antibody
  • Therapy

Chemotherapy induced anemia

  • $ 5000
  • April 2016
  • 176 pages

The chemotherapy-induced anemia (CIA) market is expected to grow marginally due to a lack of novel therapies and a static disease population. This report addresses the following questions: - How have ...

  • Blood Disease
  • Cancer
  • Chemotherapy
  • Lymphoma
  • Therapy
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on